Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients-Reference-Cited by-同舟云学术

Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients

Published:2009-10 Issue:5 Volume:23 Page:625-631
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

Felipe Claudia R.,Park Sung-In,Pinheiro-Machado Paula G.,Garcia Riberto,Casarini Dulce E.,Moreira Silvia,Tedesco-Silva Jr Helio,Medina-Pestana Jose O.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2009.00699.x/fullpdf

Reference21 articles.

1. Efficacy of SRL compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study;Kahan;Lancet,2000

2. Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation;Holt;Curr. Opin. Nephrol. Hypertens.,2002

3. Pharmacokinetic interaction between SRL and microemulsion CsA when orally administered jointly and 4 h apart in healthy volunteers;Zimmerman;J. Clin. Pharmacol.,2003

4. The effects of relative timing of SRL and CsA microemulsion formulation coadministration on the pharmacokinetic of each agent;Kaplan;Clin. Pharmacol. Ther.,1998

5. Effects of the pharmacokinetic interaction between orally administered SRL and CsA on the synergistic prolongation of heart allograft survival in rats;Stepkowski;Transplantation,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral drug delivery with nanoparticles into the gastrointestinal mucosa;Fundamental & Clinical Pharmacology;2020-08-25

2. Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients;Therapeutic Drug Monitoring;2018-02

3. Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers;Therapeutic Drug Monitoring;2017-08

4. Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation;Therapeutic Drug Monitoring;2016-02

5. Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine;Therapeutic Drug Monitoring;2016-02